# Montelukast

## Monteka 4mg

| TAH Drug Code      | [OMONT4](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMONT4)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention and long-term treatment of asthma in adults and children, including prevention of daytime and nighttime asthma symptoms, and prevention of exercise-induced bronchoconstriction. Prevention and long-term treatment of daytime and nighttime allergic rhinitis in adults and children who have previously received other anti-allergic medications but have had poor efficacy or cannot tolerate them.                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | For children aged 2-5 with asthma and/or allergic rhinitis: - Asthma: 4mg once daily at bedtime; - Seasonal or perennial allergic rhinitis: 4mg once daily in any time of the day; - Patients with both asthma and allergic rhinitis: 4mg once daily at bedtime.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Hypersensitivity to any component of the product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | Common: Abdominal pain (>=2%), Diarrhea (Pediatric, >=2%), Headache (Adult and adolescent, 18.4%; pediatric, >=2%), Otitis (Pediatric, >=2%), Otitis media (Pediatric, >=2%), Cough (>=1%), Nasal discharge (Pediatric, >=2%), Pharyngitis (Pediatric, >=2%), Sinusitis (>=1%), Upper respiratory infection (>=1%), Fever (Adult and adolescent, 1.5%; pediatric, >=2%), Influenza (Adult and adolescent, 4.2%; pediatric, >=2%) Serious: Eosinophilic granulomatosis with polyangiitis, Disorientated, Disturbance of attention, Insomnia (0.7-6% ), Memory impairment, Stuttering, Tic, Tremor, Aggressive behavior, Agitation, Anxiety (0.14% ), Depression (0.15% ), Dream disorder, Hallucinations, Irritability (0.27% ), Nightmares (0.12% ), Obsessive-compulsive disorder, Restlessness (0.11% ), Sleep walking disorder, Suicidal behavior, Suicidal thoughts |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

## SINGULAIR Chewable 5mg

| TAH Drug Code      | [OSIN](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OSIN)                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | SINGULAIR is indicated in adult & pediatric patients 6 months of age & older for the prophylaxis & chronic treatment of asthma, including the prevention of day- & nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, & the prevention of exercise-induced bronchoconstriction. SINGULAIR is indicated in adults & pediatric patients 2 years of age & older for the relief of day- & nighttime symptoms of seasonal allergic rhinitis.                                                                                  |
| Dosing             | Should be taken once daily. For asthma, the dose should be taken in the evening. For seasonal allergic rhinitis, the time of administration may be individualized. Patients with both asthma & seasonal allergic rhinitis should take only 1 TAB daily in the evening. Asthma and/or seasonal allergic rhinitis- Age > or = 15 years: 10 mg QD. Age 6-14 years: One 5 mg chewable TAB QD. Age 2-5 years: One 4 mg chewable TAB QD or one packet of 4 mg oral granules QD. Age 6 months-2 years with asthma: One packet of 4 mg oral granules QD. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Hypersensitivity to any component of Singulair.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Adverse Effects    | Abdominal pain, headache, thirst, diarrhea, hyperkinesia, asthma, eczematous dermatitis, rash. Neurologic: Headache (Adult and adolescent; 18.4%; pediatric, 2% and greater )                                                                                                                                                                                                                                                                                                                                                                    |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

## SINGULAIR 10mg

| TAH Drug Code      | [OSIN1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OSIN1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | SINGULAIR is indicated in adult & pediatric patients 6 months of age & older for the prophylaxis & chronic treatment of asthma, including the prevention of day- & nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, & the prevention of exercise-induced bronchoconstriction. SINGULAIR is indicated in adults & pediatric patients 2 years of age & older for the relief of day- & nighttime symptoms of seasonal allergic rhinitis.                                                                                  |
| Dosing             | Should be taken once daily. For asthma, the dose should be taken in the evening. For seasonal allergic rhinitis, the time of administration may be individualized. Patients with both asthma & seasonal allergic rhinitis should take only 1 TAB daily in the evening. Asthma and/or seasonal allergic rhinitis- Age > or = 15 years: 10 mg QD. Age 6-14 years: One 5 mg chewable TAB QD. Age 2-5 years: One 4 mg chewable TAB QD or one packet of 4 mg oral granules QD. Age 6 months-2 years with asthma: One packet of 4 mg oral granules QD. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Hypersensitivity to any component of Singulair.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Adverse Effects    | Abdominal pain, headache, thirst, diarrhea, hyperkinesia, asthma, eczematous dermatitis, rash. Neurologic: Headache (Adult and adolescent; 18.4%; pediatric, 2% and greater )                                                                                                                                                                                                                                                                                                                                                                    |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

